Special Seminar of the Harvard Stem Cell Institute: "Genetic engineering of hematopoiesis to treat inherited diseases and cancer"

Tuesday, October 22, 2013 at 12:00pm to 1:00pm

Program: 

Luigi Naldini, MD, PhD 

Professor of Cell and Tissue Biology with tenure, School of Medicine, "Vita-Salute San Raffaele" University

Director of the San Raffaele Telethon Institute for Gene Therapy, Milan, Italy

Member of the San Raffaele Institute Strategic Committee for the Research

Professional activities

*President of the European Society of Gene and Cell Therapy (ESGCT; since October 2012)

*Member of the Board of Directors (2005-2008) and the Advisory Council (since 2008) of the American Society of Gene and Cell Therapy (ASGCT)

*Scientific Advisor on EMEA and WHO Committees for the evaluation of novel gene transfer medicines

*Served on several Scientific Committees of the ASGCT, ESCGT, American Association of Cancer Research (AACR), International Society for Stem Cell Research (ISSCR), International Society of Cell Therapy (ISCT)

*Associate Editor: Human Gene Therapy, Mary Ann Liebert Publisher

*Member of the Editorial Board: Molecular Therapy, Gene Therapy  

 

Click here for a flyer to share with your lab.

Share
Subscribe
Event Type

Basic Science

Website

http:// www.hsci.harvard.edu/events

Recent Activity

People Going

Getting Here

Event Registration Required

This event requires registration.


NCI CCC